Alembic Pharma to acquire 45% stake in Canadian venture for pharma market expansion

Alembic Pharmaceuticals enters a Canadian joint venture with a 45% stake as it looks to strengthen its global pharma footprint. Alembic Pharmaceuticals shares closed at ₹742.75 on the NSE, up ₹5.20 or 0.71%.

Leave a Reply

Your email address will not be published. Required fields are marked *